Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (RIPK2) in human tumours

Fig. 2

Immunohistochemical (IHC) images of normal and tumour tissues of RIPK2 from patients with Prostate cancer, Endometrial cancer, and Lymphoma (A Prostate cancer; B Endometrial cancer; C Lymphoma), and the intensity of the IHC of RIPK2. The bar graph shows the IHC intensity of RIPK2 (Prostate cancer:12 patients, Endometrial cancer:12 patients, and Lymphoma:11 patients). All IHC images and patient information were derived from the HPA

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us